IperionX Limited
NASDAQ:IPXIndustrial Materials
-$0.81 today
- Market cap
- $404.73M
- Beta
- 1.35
- P/E (TTM)
- -30.0
- EPS (TTM)
- -$0.11
Volume 0.26M
Average 0.28M
IPX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
IperionX LimitedNASDAQ: IPX
Research & Development · Q2 FY2026 · quarter ended Dec 2025
Research & development grows 158593.9% year over year
Q2 FY2026 research & development of $10.8M rose 158593.9% year over year. Over 3 fiscal years it compounded at +127.8% a year.
Context
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 12.75M USD
- Year-over-year change
- +43.8%
- 4-year CAGR
- +190.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 12.75M | +43.8% |
| FY2024 | 2024-06-30 | 8.87M | +6.5% |
| FY2023 | 2023-06-30 | 8.33M | +671.6% |
| FY2022 | 2022-06-30 | 1.08M | +498.9% |
| FY2021 | 2021-06-30 | 180.19K | — |
Research & Development vs competitors
How IPX compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +43.8% is the highest of 2, against a peer median of -48.3%.
- Over three fiscal years its annual growth of +127.8% compares with a peer median of +20.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | $12.75M USD | +43.8% | +127.8% | — | |
| LTM Mar 2026 | $11.11M USD | -48.3% | +20.6% | 1027.5% | |
| LTM Mar 2026 | CA$954.46K CAD | — | — | 0.1% | |
| LTM Jul 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| LTM Jun 2025 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
BMMBlue Moon Metals Inc. | LTM Mar 2026 | $0 USD | — | — | — |
NVANova Minerals Limited | FY2025 | A$0 AUD | — | — | — |
| Peer median (excluding IPX) | — | -48.3% | +20.6% | 0.0% | |
Competitors are the stored peer set for IPX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 9.38K | 152.9K | 634.11K | 648.22K | 2.27M |
| Gross Profit | (9.38K) | (152.9K) | (634.11K) | (648.22K) | (2.27M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 180.19K | 1.08M | 8.33M | 8.87M | 12.75M |
| Selling, General & Admin | 8.11M | 11.4M | 17.3M | 13.49M | 25.53M |
| Operating Expenses | 8.11M | 21.87M | 25.62M | 22.36M | 38.28M |
| Depreciation & Amortization | 1.05K | 153.43K | 426.53K | 124.75K | 1.48M |
| EBITDA | (8.82M) | (21.64M) | (16.86M) | (22.49M) | (37.79M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (8.12M) | (21.85M) | (17.66M) | (22.46M) | (39.27M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 5.09K | 24.04K | 207.68K | 555.59K | 2.2M |
| Interest Expense | 7.52K | 45.54K | 131.03K | (90.38K) | 305.73K |
| Other Income / Expenses | (5.16M) | 348.77K | 216.8K | 773.62K | 3.92M |
| Income Before Tax | (13.28M) | (21.52M) | (17.44M) | (21.84M) | (35.35M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | (382.42K) | 0 |
| Net Income | (13.28M) | (21.52M) | (17.44M) | (22.23M) | (35.35M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.75) | (1.60) | (1.50) | (1.00) | (1.20) |
| EPS (Diluted) | (0.75) | (1.60) | (1.50) | (1.00) | (1.20) |
| Weighted Avg Shares | 13.2M | 13.46M | 16.8M | 21.78M | 29.46M |
| Weighted Avg Shares (Diluted) | 13.2M | 13.46M | 16.8M | 21.78M | 29.46M |
IperionX Limited
NASDAQ:IPX
Intrinsic Alpha fair value
Locked
Current Price
$12.06
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.